Cargando…

Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study

Detalles Bibliográficos
Autores principales: Huang, Jingjun, Cai, Mingyue, Huang, Wensou, Guo, Yongjian, Zhou, Jingwen, Liang, Licong, Lin, Liteng, Zhou, Zhimei, Lian, Hui, He, Mingji, Zhu, Kangshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850867/
https://www.ncbi.nlm.nih.gov/pubmed/34507316
http://dx.doi.org/10.1097/CM9.0000000000001537
_version_ 1784652696945426432
author Huang, Jingjun
Cai, Mingyue
Huang, Wensou
Guo, Yongjian
Zhou, Jingwen
Liang, Licong
Lin, Liteng
Zhou, Zhimei
Lian, Hui
He, Mingji
Zhu, Kangshun
author_facet Huang, Jingjun
Cai, Mingyue
Huang, Wensou
Guo, Yongjian
Zhou, Jingwen
Liang, Licong
Lin, Liteng
Zhou, Zhimei
Lian, Hui
He, Mingji
Zhu, Kangshun
author_sort Huang, Jingjun
collection PubMed
description
format Online
Article
Text
id pubmed-8850867
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88508672022-02-18 Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study Huang, Jingjun Cai, Mingyue Huang, Wensou Guo, Yongjian Zhou, Jingwen Liang, Licong Lin, Liteng Zhou, Zhimei Lian, Hui He, Mingji Zhu, Kangshun Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-01-05 2021-09-09 /pmc/articles/PMC8850867/ /pubmed/34507316 http://dx.doi.org/10.1097/CM9.0000000000001537 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Huang, Jingjun
Cai, Mingyue
Huang, Wensou
Guo, Yongjian
Zhou, Jingwen
Liang, Licong
Lin, Liteng
Zhou, Zhimei
Lian, Hui
He, Mingji
Zhu, Kangshun
Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
title Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
title_full Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
title_fullStr Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
title_full_unstemmed Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
title_short Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
title_sort transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850867/
https://www.ncbi.nlm.nih.gov/pubmed/34507316
http://dx.doi.org/10.1097/CM9.0000000000001537
work_keys_str_mv AT huangjingjun transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT caimingyue transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT huangwensou transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT guoyongjian transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT zhoujingwen transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT lianglicong transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT linliteng transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT zhouzhimei transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT lianhui transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT hemingji transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy
AT zhukangshun transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy